The FDA has granted orphan drug designation for the DiaVacs's type 1 diabetes therapy, DV-0100. The therapy halt’s the b…
Research
Diabetes Cure Research: Turning Duct Cells into Beta Cells
Bonner-Weir and other scientists have argued that either the beta cells in the pancreas continue to make copies of thems…
Volunteers Needed for NIH Diabetes Study
If you've been diagnosed with type 2 diabetes in the last 5 years, you may be eligible to help scientists test treatment…
Trial Shows Teplizumab Slows the Progression of Type 1 Diabetes
The results of the AbATE clinical trial to slow the progression of type 1 diabetes have been trickling out at conference…
GLP-1 Based Diabetes Therapies Found Safe by European Medicines Agency
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has concluded that presently…
Researchers Identify Those at High Risk for Type 1 Diabetes
Great strides have been made recently in predicting who is most likely to develop type 1 diabetes, allowing researchers …
Win A Free Copy of Targeting a Cure for Type 1 Diabetes: How Long Will We Have to Wait?
This month the American Diabetes Association published the e-book edition of Targeting a Cure for Type 1 Diabetes: How L…
Biodel to Produce Glucagon Rescue Product
Biodel has announced plans to submit a New Drug Application (NDA) to the FDA in 2015 for a novel glucagon rescue device …
Type 2 Diabetes in Youth More Aggressive Than in Adults, Even When Treated
According to a series of study results being published in a special issue of Diabetes Care youth with type 2 diabetes e…
Cure for Type 1 Diabetes and MS? Discovery of Immune Suppressing Protein CD52
Dr. Harrison and his team identified that some T cells express a molecule on their surfaces, CD52, that is capable of su…
